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The glutathione S-transferases (GSTs) are involved in biotransformation and detoxiﬁcation of cadmium (Cd). Genetic polymor-
phisms in these genes may lead to interindividual variation in Cd susceptibility. The objective of this study was to assess the
associationofGSTs(GSTT1,GSTM1,andGSTP1Val105Ile)polymorphismswithbloodCdconcentrationsinanonoccupationally
exposed population. The 370 blood samples were analyzed for Cd concentration and polymorphisms in GSTs genes. Geometric
mean of blood Cd among this population was 0.46 ± 0.02μg/L (with 95% CI; 0.43–0.49μg/L). Blood Cd concentrations in
subjects carrying GSTP1 Val/Val genotype were signiﬁcantly higher than those with Ile/Ile and Ile/Val genotypes. No signiﬁcant
diﬀerencesinbloodCdconcentrationsamongindividualwithgenedeletionsofGSTT1andGSTM1wereobserved.GSTP1/GSTT1
and GSTP1/GSTM1 combinations showed signiﬁcantly associated with increase in blood Cd levels. This study indicated that
polymorphisms of GSTP1 combined with GSTT1 and/or GSTM1 deletion are likely to inﬂuence on individual susceptibility to
cadmium toxicity.
1.Introduction
Cadmium (Cd) is widely dispersed in the environment and
causes various diseases, both in occupationally exposed indi-
viduals and in the general population. The general popula-
tion may be exposed to cadmium through ingestion of food
and drinking water, inhalation of particulates from ambient
air or tobacco smoke, or ingestion of contaminated soil or
dust.Themajorlong-termtoxiceﬀectsoflow-levelcadmium
exposure are renal injury, obstructive pulmonary disease, os-
teoporosis,andcardiovasculardisease[1].Cadmiumisalsoa
potent human carcinogen and has been associated with can-
cers of the lung, prostate, pancreas, and kidney [2].
In human body, Cd is basically taken up by the liver. In
the liver, Cd can bind with glutathione (GSH) and be excret-
ed into bile. Moreover, Cd can bind to metallothionein (MT)
and be stored. Some Cd bound to MT leaks into the plasma
and then is taken up by the kidney. The balance between
CdMT and nonbound Cd in renal tissue may be responsible
for the degree of Cd nephrotoxicity [3, 4]. Therefore, sus-
ceptibility to Cd toxicity among individual may probably be
related to genetic variations of Cd-metabolizing enzymes.2 Journal of Toxicology
Glutathione S-transferase (GST) gene is one of the potential
candidate susceptibility genes-because it plays a signiﬁcant
role in Cd biotransformation and detoxiﬁcation [5]. The
principal function of GST enzymes is conjugations of hy-
drophobic and electrophilic compounds with reduced glu-
tathione. The intracellular binding reaction with GSH is cat-
alyzed by the GSTs and leads to stable GSH-metal conjugates
being transported out of the cell and excreted via feces and
urine [6]. Seven GSTs gene families (Alpha, Mu, Pi, Theta,
Sigma, Omega,a n dZeta) have been described and genetic
polymorphisms have been reported for GSTM1, GSTP1,a n d
GSTT1,resulting ineitherdecreasedoralteredenzymeactiv-
ity [7, 8]. GSTT1 and GSTM1 are particularly important,
because they have a deletion polymorphism resulting in
impaired catalytic activity, which is associated with greater
sensitivity to toxic compounds. The homozygous deleted
(null genotype) of GSTT1 and GSTM1 genotypes have
been associated with enhanced genotoxicity and are believed
to be key factors in determining susceptibility to diseases
associated with exposure to xenobiotics such as cancer [9].
Polymorphism of GSTP1 has been found in the coding re-
gion. The variant allele of GSTP1 Val105Ile encodes valine
(Val) instead of isoleucine (Ile) at codon 105 due to a base
pair exchange, where G substitutes A. These substitutions
were linked to a change in enzyme activity [8]. Polymor-
phisms in GSTT1, GSTM1,a n dGSTP1 may be associated
with increased susceptibility to cadmium toxicity [10].
Given that metabolism and detoxiﬁcation of cadmium
(as an electrophile) is mediated by glutathione and GSTs
are involved in the complexation of electrophilic substances
with glutathione, it is reasonable to hypothesize that genetic
polymorphisms in GST genes could result in diﬀerences in
sensitivity to cadmium.
In recent years, the possibilities of applying molecular
techniques to toxicogentics are considerably focused, espe-
cially for medical investigations and determinations of fac-
tors inﬂuencing chemical poisonings. These include bio-
chemical and genetic determinants related to acute and
chronic eﬀects. To our knowledge, there are limited data on
genetic predisposition inﬂuence on cadmium detoxiﬁcation
in the human body. Therefore, this study investigated the
association of glutathione S-transferase genes (GSTT1,
GSTM1,a n dGSTP1) polymorphisms and blood cadmium
concentration in a nonoccupationally exposed population.
2.MaterialsandMethods
2.1. Study Subjects. The Electric Generating Authority of
Thailand (EGAT) STUDY was the ﬁrst cohort study of
chronic disease in Thailand, originally designed in 1985
(known as EGAT 1), and mainly covered multidisciplinary
researches related to cardiovascular disease (CVD) risk fac-
tors such as nutrition and toxicology. The 370 subjects in
this study were participants in the third survey of EGAT 2
in 2009 (the ﬁrst survey started in 1998 and second survey in
2003) [11]. Participants completed a self-administered ques-
tionnaire, underwent a physical examination, and provided
fasting blood samples. The study was approved by the
Committee on Human Rights Related to Researches Involv-
ing Human Subjects, Faculty of Medicine, Ramathibodi
Hospital, Faculty of Tropical Medicine, Mahidol University,
in accordance with the ethical standards laid down in the
1964 Declaration of Helsinki. All participants gave their
informed consent prior to their inclusion in the study.
Toxicological proﬁle of heavy metals was investigated in
both ﬁrst and third surveys of EGAT 2, and further genetic
analysis started in 2009. Ten milliliters of blood were collect-
ed by venipuncture into EDTA and heparinized tubes from
each subject and immediately centrifuged at 2000g. Buﬀy
coat, erythrocytes, and plasma were separated and stored at
−20◦C until genotyping analyses and biochemical measure-
ment were performed.
2.2. Determination of Cadmium in Blood. Whole blood cad-
mium concentrations were measured by graphite furnace
atomic absorption spectrometry (GFAAS) with Zeeman
background correction after dilution of the blood (1:10)
with Triton X-100 solution containing diammonium hydro-
gen phosphate and nitric acid [12]. The concentration was
expressed as micrograms per liter.
2.3. Genotype Analyses. The genomic DNA was extracted
from the lymphocytes by a modiﬁed salting out procedure
[13]a n df r o z e na t−20◦C until analysis. The genetic poly-
morphisms of GSTM1, GSTT1,a n dGSTP1 were performed
by real-time polymerase chain reaction (real-time PCR)
according to the method of TaqMan SNP Genotyping Assays
on an ABI 7500 instrument (Applied Biosystems, Foster City,
CA, USA), in 96-well format. The TaqMan Assay included
the forward target-speciﬁc polymerase chain reaction (PCR)
primer, the reverse primer, and the TaqMan MGB probes
labeled with 2 special dyes: FAM and VIC. The concen-
trations of probes were 0.04μM. Ampliﬁcation of 20ng of
DNA was performed during 40 cycles in a reaction volume
of 10μL. TaqMan Universal PCR Master Mix was used for
analysis.Thermocyclingconditionswere95◦Cfor15seconds
follow by 60◦C for 1 minute. Information of speciﬁc probe
and primers are available on the National Cancer Institute’s
SNP500 database web page at http://variantgps.nci.nih.gov/
[14].
2.4. Statistical Analysis. Statistical analyses were carried out
using the SPSS 16.0 for window software (SPSS, Inc.,
Chicaco, IL, USA). Cadmium data were log-transformed to
achieve normal distribution. The values were expressed as
geometric means. The comparisons between variables were
examined by the Student’s t-test and analysis of variance
(ANOVA). Genotype distribution was analyzed with χ2.T h e
eﬀects of all GSTs gene on blood cadmium were evaluated by
linear regression analysis. A P value of 0.05 was used as the
criterion for statistical signiﬁcance.
3. Results
The subjects of this study consisted of 370 employees
of EGAT. The geometric mean of the blood cadmiumJournal of Toxicology 3
Table 1: The geometric mean of blood cadmium concentrations in a nonoccupational exposed population.
Characteristics n Blood cadmium concentration (μg/L)
GM ±SE 95% CI
Total 370 0.46 ±0.02 0.43–0.49
Gender
male 267 0.46 ±0.02 0.42–0.50
female 103 0.45 ±0.03 0.40–0.50
Age (yrs)
45–55 yrs 144 0.45 ±0.03 0.40–0.51
>55 yrs 226 0.46 ±0.02 0.42–0.50
Smoking habit
nonsmoker 294 0.41 ±0.02a 0.38–0.42
Smoker 76 0.72 ±0.04 0.62–0.85
Alcohol consumption
Nondrinker 178 0.44 ±0.02 0.40–0.48
Drinker 192 0.47 ±0.02 0.43–0.53
aSigniﬁcantly diﬀerent from smoker, P<0.05 Student’s t-test.
GM = Geometric mean.
95% CI = 95% Conﬁdence interval.
Table 2: Geometric means of blood cadmium concentrations in a nonoccupational exposed population categorized by diﬀerent genotype.
Gene Genotype Frequency Blood cadmium (μg/L)
n %G M ± SE
GSTT1 Null 121 32.7 0.49 ±0.03
Present 249 67.3 0.44 ±0.02
GSTM1 Null 213 57.6 0.47 ±0.02
Present 157 42.4 0.44 ±0.02
GSTP1-105 Ile/Ile 212 57.3 0.45 ±0.02
rs1695 Ile/Val 139 37.6 0.45 ±0.03
Val/Val 19 5.1 0.71 ±0.08a,b
a,bSigniﬁcantly diﬀerent GSTP1 from Ile/Ile and Ile/Val genotypes, respectively, P<0.05.
concentrations was 0.46 ± 0.02μg/L (with 95% CI; 0.43–
0.49μg/L) (Table 1). The level of blood cadmium in smokers
was signiﬁcantly higher than those in nonsmokers (0.72
versus 0.42μg/L, P<0.05). There were no signiﬁcantly
diﬀerence in blood cadmium concentration between gender
and alcohol consumption.
The distribution of genetic polymorphisms and mean of
blood cadmium concentration for each genotype are shown
in Table 2. All genes were in Hardy-Weinberg equilibrium
(P-value >0.05). The GSTT1 present was the most prevalent
genotype found in study population (67.3%). Homozygous
variant of GSTP1 Val/Val was the lowest genotype in study
population (5.1%).
Subjects with GSTP1 Val/Val had signiﬁcantly higher
blood cadmium concentration (0.71μg/L) than did the
GSTP1 wild-type (Ile/Ile) (0.45μg/L) and heterozygous
variant of GSTP1 Ile/Val (0.45μg/L, P<0.05). There were
no signiﬁcant diﬀerences on blood cadmium concentration
among subjects with GSTT1 and GSTM1 deletions.
Three of the putative genes with risk genotypes were
examined (Table 3). The linear regression analysis indicated
a function of genetic polymorphisms on blood Cd level. In
this model, the results of regression coeﬃcient of GSTT1
Val105Ile (β = 0.59, P = 0.034) exhibited strong potential
predictors on blood Cd concentration. Considering the
signiﬁcant impact of GSTP1 variant allele and the very small
number of GSTP1 Val/Val genotype (n = 19), we combined
thesevariant-allelesubjectswithheterozygousgenotype(n =
158). Moreover, signiﬁcant eﬀect of gene combination was
observed for GSTP1 variant allele with GSTM1 and GSTT1.
Combined GSTP1-105 Ile/Val and Val/Val with GSTM1 and
GSTT1 null genotypes were shown as statistical predictors
of blood Cd concentrations (β = 0.67, P = 0.044 and
β = 0.72, P = 0.038, resp.). However, no other eﬀects of
gene combinations were observed on blood Cd levels.
4. Discussion
A nonoccupationally exposed population may be exposed
to cadmium through ingestion of food and drinking water
and inhalation of particulates from ambient air or tobacco
smoke. In the present study, we found that the geometric4 Journal of Toxicology
Table 3: Regression coeﬃcient for blood cadmium by GSTP1 Val105Ile and interaction between GSTP1 Val105Ile and GSTT1 and GSTM1.
Genotype Blood cadmium
n β (S.E.)
a P valueb
GSTP1 Val105Ile
GSTP1 Ile/Ile 212 0.27 (0.19) 0.324
GSTP1 Ile/Val 139 0.35 (0.22) 0.296
GSTP1 Val/Val 19 0.59 (0.39) 0.034
GSTM1 and GSTP1 Val105Ile
GSTM1 +/GSTP1 Ile/Ile 96 − 0.14 (0.23) 0.462
GSTM1 +/GSTP1 Ile/Val and Val/Val 82 0.32 (0.26) 0.108
GSTM1 –/GSTP1 Ile/Ile 126 0.29 (0.17) 0.288
GSTM1 –/GSTP1 Ile/Val and Val/Val 68 0.67 (0.46) 0.044
GSTT1 and GSTP1 Val105Ile
GSTT1 +/GSTP1 Ile/Ile 121 0.20 (0.13) 0.142
GSTT1 +/GSTP1 Ile/Val and Val/Val 89 0.18 (0.21) 0.296
GSTT1 –/GSTP1 Ile/Ile 108 0.39 (0.22) 0.103
GSTT1 –/GSTP1 Ile/Val and Val/Val 52 0.72 (0.58) 0.038
aRegression coeﬃcients.
bP value were obtained by linear regression after controlling for sex, age, BMI, smoking status and alcohol consumption.
mean of the blood cadmium concentration in a nonoccu-
pationally exposed population was in the acceptable range
(<5.0μg/L) [1]. The result agreed with the previous report in
Thai population [15].
Gender, age, and alcohol consumption were no inﬂu-
encesonbloodcadmiumlevelsamongthisstudypopulation,
similar to the study by Bat´ ariov´ a et al. [16]. Cigarette smok-
ing was found to be signiﬁcantly related to blood cadmi-
um concentration. Smokers had signiﬁcantly higher blood
cadmium concentration than nonsmokers (P<0.05)
(Table 1). It could be explained that cigarette smoking was
a major source of nonoccupational cadmium exposure be-
cause of cadmium in the tobacco. It had been reported that
cigarettes contain cadmium in concentrations ranging from
1.56 to 1.96μg/cigarette [17]. Blood cadmium levels ob-
served in this study group appeared to be similar to those
reported in the other studies [15, 16, 18, 19].
Polymorphisms in genes, which involved in metabolism
of cadmium, were analyzed including GSTT1, GSTM1,a n d
GSTP1 to explore the genetic susceptibility to cadmium tox-
icity. In the present study, all tested genotype frequencies
were in Hardy-Weinberg equilibrium. The GSTT1 present
was the most prevalent genotype found in study population
(67.3%) (Table 2). Homozygous variant of GSTP1 Val/Val
was the lowest genotype in study population (5.1%). The
null genotypes of GSTT1 and GSTM1 were found with a
frequency of 32.7%, and 57.6%, respectively, while GSTP1
Ile/Ile, Ile/Val, Val/Val genotype frequencies were 57.3%,
37.6%,and5.1%,respectively.Thesimilargenotypefrequen-
cies were reported in Thai population [20–22].
The GST gene family is involved in the detoxiﬁcation
of electrophilic compounds by conjugating them with GSH
and immediately excreted via the bile or urine. The level of
GST expression is a crucial factor determining the sensitivity
of cell to toxic chemical [23]. This gene family comprises
several genes, and many of them are polymorphic in human.
GSTP1 exhibits a missense mutation at codon 105, which
substitutes Val to Ile. The polymorphism in GSTP1 both
amino acid exchanges are in the active site of the enzyme
and inﬂuence the activity toward diﬀerent substrates [24].
GSTM1 and GSTT1 exhibit deletion alleles, which eliminate
enzyme activity [25]. In the present study, subjects with
the GSTP1 homozygous variant (Val/Val) had signiﬁcantly
higher blood cadmium level than did those with Ile/Val and
wild-type (Ile/Ile) genotype. The possible explanation would
be the substitution of Ile→Val in GSTP1 change catalytic
activity of the corresponding GSTs [25, 26]. The change
in catalytic activity may reduce in Cd-GSH conjugates and
excretion, which results in cadmium accumulated in blood.
Since the variation in GSTP1 genotype is associated with
variation of blood cadmium concentration. Therefore, it
could be assumed that GSTP1 play a more important role in
variation of blood cadmium concentrations than the other
investigated GST polymorphisms.
Withregardstogene-geneinteractions,thestudyshowed
that GSTP1 Val variant allele had signiﬁcantly associated
with higher blood cadmium concentration when taking into
account GSTT1 null or GSTM1 null genotypes (Table 3).
This could be explained by GST conjugated reactive com-
pounds to GSH prior to their excretion from the body. The
deletion of GSTT1 and GSTM1 genes reduces the catalytic
activity [23], and polymorphism in GSTP1, changes catalytic
activity of the corresponding GSTs [26]. Therefore, the pol-
ymorphisms may aﬀect the conjugation and excretion of
cadmium, which results in accumulation of this metal in
blood. Moreover, not only a single genetic polymorphism
of GSTs genes which may alter the enzyme activity, but also
combinations of polymorphism may be more important in
determining catalytic activities, expression of enzyme, and
interindividual variability of disposition and response toJournal of Toxicology 5
substrates. Therefore, this study indicated that the inter-
action of GSTP1 Val variant allele with GSTT1 null or
GSTM1 null could aﬀect the elevation of blood cadmium
concentration.
5. Conclusion
These results suggested that polymorphisms of GSTP1 and
combined genotypes of GSTP1 with GSTT1 and GSTM1
may be responsible for susceptibility to cadmium toxicity.
Theﬁnding conﬁrmsthat interindividual variations in blood
cadmium concentrations are not entirely attributable to en-
vironmental exposure but also genetic background. From
the point of view of toxicogenetics, some information of
gene-environment and gene-gene interactions is provided by
our ﬁndings. Further studies are needed to investigate the
GSTT1, GSTM1,a n dGSTP1 mutations and their enzyme
activities related to cadmium concentrations. Moreover, ge-
netic variations of GSTs and metallothionein in environ-
mentally and occupationally exposed individuals should be
considered, particularly in respect of mechanism of Cd-
induced toxicity.
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